SUSAN HOFF-THOMAS: Open Payments
NPI 1174525158 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 8 payments from 5 companies in 2025. Trend: 2023 $170 · 2024 $227 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $124 |
| Merck Sharp & Dohme LLC | 1 | $100 |
| Gilead Sciences, Inc. | 3 | $60 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $17 |
Products named: DOVATO, ZERBAXA, VOWST, Rezzayo, RUKOBIA.
Industry payments across KY — which companies pay providers there.
